Simplex Trading’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Buy
68,600
+56,700
+476% +$1.08M ﹤0.01% 2278
2025
Q4
$259K Sell
11,900
-25,300
-68% -$725K ﹤0.01% 3966
2025
Q3
$1.21M Sell
37,200
-11,000
-23% -$406K ﹤0.01% 2851
2025
Q2
$1.71M Buy
48,200
+34,000
+239% +$1.1M ﹤0.01% 2250
2025
Q1
$481K Buy
14,200
+10,900
+330% +$391K ﹤0.01% 3446
2024
Q4
$107K Sell
3,300
-1,700
-34% -$70.4K ﹤0.01% 5109
2024
Q3
$243K Sell
5,000
-8,100
-62% -$431K ﹤0.01% 4326
2024
Q2
$580K Sell
13,100
-34,800
-73% -$1.61M ﹤0.01% 3506
2024
Q1
$2.69M Sell
47,900
-3,000
-6% -$181K ﹤0.01% 2119
2023
Q4
$3.06M Buy
50,900
+38,400
+307% +$2.43M ﹤0.01% 1989
2023
Q3
$839K Sell
12,500
-13,700
-52% -$952K ﹤0.01% 2853
2023
Q2
$1.81M Sell
26,200
-3,800
-13% -$248K ﹤0.01% 2043
2023
Q1
$1.45M Sell
30,000
-8,900
-23% -$435K ﹤0.01% 2235
2022
Q4
$1.94M Sell
38,900
-19,200
-33% -$930K ﹤0.01% 1888
2022
Q3
$2.37M Sell
58,100
-800
-1% -$37.5K ﹤0.01% 1803
2022
Q2
$3.24M Buy
58,900
+50,800
+627% +$2.15M ﹤0.01% 1433
2022
Q1
$294K Buy
8,100
+6,500
+406% +$257K ﹤0.01% 4583
2021
Q4
$74K Buy
1,600
+1,400
+700% +$71K ﹤0.01% 6697
2021
Q3
$8K Hold
200
﹤0.01% 9050
2021
Q2
$8K Buy
200
+198
+9,900% +$6.73K ﹤0.01% 9220
2021
Q1
$5K Buy
+2
New +$55 ﹤0.01% 8210

Other funds holding LEGN

Simplex Trading's LEGN Position: Q1 2026 in Review

Simplex Trading sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 29,432 shares — an estimated $561K sold.

Simplex Trading first reported a position in LEGN in Q1 2021 and held it in 10 quarters. The position peaked at $640K in Q4 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Simplex Trading reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 29,432 Legend Biotech shares in Q1 2026, an estimated $561K.
  • Simplex Trading first reported a position in Legend Biotech in Q1 2021 and held it in 10 quarters.
  • Simplex Trading's Legend Biotech position peaked at $640K in Q4 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.